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Abstract
Background: The objective of this review was to assess the uptake of WHO recommended integrated perinatal prevention
of mother-to-child transmission (PMTCT) of HIV interventions in low- and middle-income countries.
Methods and Findings: We searched 21 databases for observational studies presenting uptake of integrated PMTCT
programs in low- and middle-income countries. Forty-one studies on programs implemented between 1997 and 2006, met
inclusion criteria. The proportion of women attending antenatal care who were counseled and who were tested was high;
96% (range 30–100%) and 81% (range 26–100%), respectively. However, the overall median proportion of HIV positive
women provided with antiretroviral prophylaxis in antenatal care and attending labor ward was 55% (range 22–99%) and
60% (range 19–100%), respectively. The proportion of women with unknown HIV status, tested for HIV at labor ward was
70%. Overall, 79% (range 44–100%) of infants were tested for HIV and 11% (range 3–18%) of them were HIV positive. We
designed two PMTCT cascades using studies with outcomes for all perinatal PMTCT interventions which showed that an
estimated 22% of all HIV positive women attending antenatal care and 11% of all HIV positive women delivering at labor
ward were not notified about their HIV status and did not participate in PMTCT program. Only 17% of HIV positive antenatal
care attendees and their infants are known to have taken antiretroviral prophylaxis.
Conclusion: The existing evidence provides information only about the initial PMTCT programs which were based on the
old WHO PMTCT guidelines. The uptake of counseling and HIV testing among pregnant women attending antenatal care
was high, but their retention in PMTCT programs was low. The majority of women in the included studies did not receive
ARV prophylaxis in antenatal care; nor did they attend labor ward. More studies evaluating the uptake in current PMTCT
programs are urgently needed.
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Introduction
In 2010, an estimated 16.8 million women and 3.4 million
children were HIV positive [1]. Each day an estimated 1000
children under the age of 16 acquire HIV infection [1], over 90%
of them due to mother-to-child transmission (MTCT) of HIV [1].
Transmission of HIV from mother to child can be reduced from
15–40% to 1% by effective prevention of mother to child
transmission (PMTCT) of HIV programs [1].
When PMTCT programs were initially introduced in low- and
middle-income countries, they were stand-alone programs, with
gradual integration into maternal and newborn healthcare services
[2,3] as one of the key strategies to improve coverage, achieve
universal access to PMTCT programs [4–8], and improve the
quality of care delivered through better and synergistic use of
scarce human and financial resources [7]. Implementing PMTCT
programs integrated to routine healthcare services might help to
reduce the stigma often experienced by HIV infected people
[9,10]. However, many women in low- and middle-income
countries do not attend maternal and child healthcare services
[11]. Integrated or not, PMTCT services experience loss-to follow-
up at each step of the program delivery: from the first contact,
through counseling, HIV testing, collecting results, receiving
antiretroviral therapy (ART) or prophylaxis, safe delivery practic-
es, infant feeding recommendations up to postnatal follow-up;
thereby reducing program effectiveness.
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The uptake of PMTCT program is also influenced by the type
of interventions implemented. The World Health Organization
(WHO) has recommended the use of opt-out (i.e. offering testing
routinely to all women entering care with an option to ‘‘opt-out’’
of testing), rapid HIV testing with return of results on the same day
[12], and the use of virological tests in infants [13]. Virological test
can be used earlier than an antibody test to identify HIV infections
in infants since maternal HIV antibodies transferred passively
during pregnancy can persist for as long as 18 months in children
born to HIV-infected mothers and the interpretation of positive
HIV antibody test results is more difficult in children below this
age [14,15]. The aim of the WHO recommended HIV testing
methods is to increase the number of women and children tested
for HIV and knowing their serostatus as well as to improve access
to HIV treatment.
In 2001, at the United Nations General Assembly Special
Session (UNGASS), a goal was set to reduce the proportion of
HIV infected infants by 50% by the year 2010 [16]. In order to
achieve this target, an estimated 80% of pregnant women and
their infants would need to have access to essential prevention,
treatment and care [17]. Despite substantial international efforts,
the progress on 4 th and 5 th Millennium Development Goals has
been lagging behind the target [18,19].
Low coverage of PMTCT programs prompted the UN
Secretary General and key UN agencies to call for increased
domestic and international financing to address health of women
and children to reach the 4 th and 5 th Millennium Development
Goals and to expand the PMTCT coverage [20]. Furthermore,
the UN Secretary General, G8 countries, and the Global Fund to
Fight AIDS, Tuberculosis and Malaria, in collaboration with its
key partners the Joint United Nations Program on HIV/AIDS
(UNAIDS), WHO, the United Nations Children’s Fund (UNI-
CEF), the United Nations Population Fund (UNFPA) and the
Children’s Investment Fund Foundation (CIFF) have committed
to further develop and improve the quality and effectiveness of
PMTCT services in low- and middle-income countries [20,21].
Integration of PMTCT with other healthcare services is a crucial
component of this initiative [4,7,8,13,22].
Given the unacceptably large number of children affected by
HIV at birth [1], poor PMTCT coverage [11], the potential
impact of successful PMTCT programs and the international
commitment to the improvement of these services, it is important
to assess the effectiveness of integration of PMTCT services with
other health services, such as maternal, newborn, and child health
services. While several literature overviews explore integration of
individual PMTCT interventions, the evidence on the uptake of
these programs has not been systematically assessed [23–26]. The
objective of this systematic review is to assess the uptake of
integrated PMTCT programs in low- and middle-income
countries.
Methods
Definition
This review focuses on the integration of the third prong of
PMTCT interventions (Text S1), i.e. perinatal PMTCT interven-
tions, which consist of HIV testing and counseling, provision of
ART or antiretroviral (ARV) prophylaxis to women, safe delivery
practices, infant feeding counseling, provision of ARV prophylaxis
and HIV testing to the infant [27,28]. The PMTCT guidelines
have changed several times since the beginning of PMTCT
programs. This systematic review aims to present the overall
uptake of PMTCT interventions and includes studies that
implemented or followed different versions of guidelines over the
study time period.
We considered eligible studies on integration of PMTCT with
antenatal care, labor ward care, postnatal/follow-up care, child
healthcare services (e.g. immunization), nutrition services, volun-
tary counseling and testing (VCT) centers, HIV clinics, sexually
transmitted infection (STI) clinics, reproductive health services and
out-patient clinics. Given that PMTCT interventions in many
settings are integrated with maternal and child health services, we
developed a framework describing the integration of PMTCT
program with antenatal care, labor ward and postnatal care (Table
S1).There is no internationally agreed definition of integrated care
[29–32]. We defined the integration of PMTCT interventions as
joining of service delivery of PMTCT programs with other health
care services, either at a single point of access (unified, full) or
through referrals [33].
Inclusion and exclusion criteria
We included observational studies performed in low- and
middle-income countries as defined by the World Bank [34].
Studies had to focus on pregnant women, women in labor or in
postpartum and infants with unknown HIV serostatus at
enrolment in an integrated PMTCT program.
The primary outcome was the uptake of PMTCT programs, i.e.
the proportion of women and children receiving individual
PMTCT interventions (Text S2). In addition, we collected other
relevant outcomes such as the proportion of HIV negative infants
born to HIV positive women, costs, the impact on human
resources, the quality of care, stigma, inequalities in access,
barriers to implementation and sustainability of integrated
programs and the impact on attendance (Text S2). We also
included information about the follow-up i.e. provision of ART
and co-trimoxazole to HIV positive women and HIV positive
infants after the delivery. Exclusion criteria are listed in Text S3.
Search strategy
We performed a comprehensive search to identify all relevant
research regardless of the publication status, in any language with
an English abstract. The search was conducted from 1990 (time of
the first implementation of PMTCT programs) to August 2010.
We used a highly sensitive search strategy developed in
collaboration with the Cochrane HIV/AIDS Review Group.
The search strategy did not entail search terms related to
integrated care because in some studies ‘‘integration’’ could have
been omitted or be apparent only from the description of service.
We examined description of service delivery in each study to
decide if it fits our definition of healthcare service integration.
Electronic searches
We searched the following electronic databases: MEDLINE,
EMBASE, the Cochrane Library, WHO The Global Health
Library, Global Health CAB abstracts, CINAHL, POPLINE,
PsychINFO, Sociological Abstracts, ERIC, the NLM Gateway
system, and the Controlled-trials register and the WHO Interna-
tional Clinical Trials Registry for ongoing trials on PMTCT. We
also searched several grey literature sources: New York Academy
of Medicine Grey Literature Collection, Google Scholar, Open
SIGLE, British Library Catalogue, AEGIS and ProQuest Disser-
tation & Theses Database (Text S4). We contacted authors of
conference proceedings for additional information.
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Screening process and data extraction
Two review authors independently performed selection of
studies and data extraction. Disagreements between authors were
resolved by discussion, consensus and consultation with a third
review author. We screened titles and abstracts and then full-texts
for eligibility. Data from the included studies were extracted using
a standardized data extraction sheet (Table S2).
Data analysis
We analyzed the data presented in the studies and performed
narrative synthesis. The included studies used different denomi-
nators to present the proportion of participants receiving perinatal
PMTCT intervention which we recalculated and standardized
(Text S5). We separately analyzed the studies which described the
implementation of the PMTCT program in antenatal care and at
labor ward level. For pregnant women enrolled at antenatal care
we separately described the proportion of women receiving ARV
Figure 1. PRISMA Flow diagram.
doi:10.1371/journal.pone.0056550.g001
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prophylaxis in antenatal care, the proportion receiving it at labor
ward and the total proportion of women who received ARV
prophylaxis at delivery (consisting of women who received ARV
prophylaxis in antenatal care and self-reported that they have
taken it during home delivery and women who took the
prophylaxis at the labor ward).
Statistical analysis was carried out based on non-parametric
tests since distributional assumptions were not satisfied. The
Wilcoxon rank sum test was applied to perform all comparisons
between two groups [35]. Differences in outcome for the three
World Bank income groups, namely low-, lower-middle, upper-
middle income countries were tested by an extended rank sum test
developed by Cuzick [36]. We used a rank sum trend test, which is
a natural extension of the Wilcoxon rank sum test for two groups,
as a non-parametric statistic to consider the trend between more
than two groups.
We designed two cascades with the data from the studies
reporting on the uptake of each step of perinatal PMTCT
programs [37,38]. The first cascade presents integration of
PMTCT interventions in antenatal care and the second cascade
illustrates the integration of PMTCT interventions at labor ward.
Both cascades pool the studies weighted by the number of
participating women. The fractions are relative to the number of
women attending antenatal care in the first cascade and the
number of women eligible for HIV test at labor ward in the second
cascade. The first cascade assumes that the HIV prevalence is
equal among women who accepted and those who declined
testing. This assumption is probably conservative as women might
decline testing since they feel likely to be positive. Hence, the real
number of HIV positive among women who declined testing is
probably higher than our estimate. However, we imply that
selection into testing did not result in a higher number of positive
HIV tests, which could arguably be the case if once tested women
refrain from a repeated test as they correctly assume that they are
still negative. We made the same assumption for the second
cascade to estimate the proportion of unidentified HIV positive
women.
Results
Study characteristics
Our search strategy identified 28 654 references (Figure 1 and
Table S3). One hundred and twenty one articles and 218 relevant
conference abstracts passed the first screening of titles and
abstracts. After full text assessment, we excluded 86 articles (Table
S4). We contacted authors of relevant conference abstracts for
further information resulting in one included abstract. Forty one
studies met inclusion criteria (Table 1 and Figure 1). We found two
second reports: a French version of an English article [39], and a
brief additional description of a program already reported in one
of the included studies [40]. Except one article in Spanish [41], all
the included studies were in English.
Twenty five studies were conducted in Sub-Saharan Africa [42–
66], six in Latin America-Caribbean [41,67–71], nine in Asia [72–
80], and one in Ukraine [81]. Of the 41 included studies, 17
described PMTCT programs in low-income [46–50,52–55,57–
59,61–63,67,80], 15 in lower-middle income [41,43–
45,56,64,65,70,72,74,76–79,81], and nine in upper-middle in-
come countries [42,51,60,66,68,69,71,73,75]. The presented
PMTCT programs were implemented at different time periods
between years 1997 and 2006 (Figure S1). Twelve programs
occurred in countries where HIV prevalence was between 5% and
10% (Table S5). The general HIV prevalence in 18 studies was
less than 5% and more than 10% in 11 programs, all of which
were implemented in Africa (Table S5). PMTCT interventions
were mostly integrated with maternal and child health services, i.e.
antenatal care, labor wards, and postnatal care. The infant follow
up was integrated with immunization centers in two studies
[61,63]. In one study the PMTCT was integrated with HIV/AIDS
treatment centers [81]. Participants, staff, setting and interventions
from integrated PMTCT programs are presented in Texts S6 and
S7 and Table S6.
Outcomes
Primary outcomes. In 34 studies women were enrolled in
integrated PMTCT program in antenatal care. In most of these
studies (n = 28), women were followed from antenatal care until
delivery [41–51,53–59,61–69,71,74–77,79,81]. In seven studies
women were enrolled into the integrated PMTCT programs at
labor ward [60,70–73,75,78]. In two studies women entered the
integrated program both at antenatal and labor ward care [80,82].
Integration of perinatal PMTCT program with antenatal
care. The main outcomes from the 34 studies which reported on
the PMTCT program integrated in antenatal care are displayed in
Table 2. We performed subgroup analyses to analyze the impact
of different strategies on the coverage within studies focusing on
antenatal care integration (Text S8).
Integration of perinatal PMTCT program with labor
ward care. The primary outcomes reported in the studies
which focused on integration of PMTCT with labor ward are
shown in Table 3 [52,60,70–73,75,78,80]. In those studies
pregnant women were eligible for HIV testing if they had
unknown or undocumented HIV status at their entrance in labor
ward. Additionally, in two studies from Russia women who had a
previous negative HIV test performed before 34 weeks of
pregnancy were also considered eligible for repeat testing [75].
Integration of perinatal PMTCT program with labor
ward care: safe delivery. Only nine studies had quantitative
data on safe delivery practices [41,45,47,56,58,66,68,69,71]. In
two studies performed in low-income countries caesarean section
was not available [47,58]. In the other seven studies the proportion
of HIV positive pregnant women who underwent elective
caesarean section varied from 17% to 63% (median 28%)
[41,45,56,68,69,71]. Five of these studies were performed in
upper-middle income countries [41,66,68,69,71,83] and two in
lower-middle income countries [45,56].
Fifteen studies provided extractable data on the proportion of
women who entered into the PMTCT program in antenatal care
and delivered at hospital [41,45,47,54,56–
59,61,64,66,68,69,74,77]. The median proportion was 60% (range
19–100%), and it significantly varied across the World Bank
income groups: 44% (range 19–60%) in studies performed in low-
income [47,54,58,59,61], 86% (range 43–100%) in lower-middle
income [45,56,64,74,77], and 100% (range 89–100%) among the
upper-middle income countries (P,0?0001) [41,66,69].
Integration of perinatal PMTCT program with postnatal/
follow-up care. The outcomes from the studies reporting
coverage of infant ARV prophylaxis and HIV testing are
presented in Table 4. Within the 13 studies with data on infant
testing [41,47,51,56,57,64,66,68,69,71,75,78,79], six used a rapid
test at 12, 15 and 18 months [47,51,64,68,69,71], while in seven a
PCR test or viral load was used within the first six months of life
[41,56,57,66,75,78,79]. The proportion of children tested at least
once was not significantly different between those two groups of
studies, 82% (range 48–100%) versus 76% (range 44–100%),
P= 0.548.
A study on integrated PMTCT program in Vietnam is
described separately due to particularities of the program. In this
The Uptake of Integrated PMTCT Programs
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Table 1. Characteristics of included observational studies.
Author/Year/
Location/Study
period
Participants/
Sample size
(n)/Setting Settings Program Integration
Opt in vs opt out/Type
of HIV test/ARV regimen
(Woman/Infant) Primary outcomes reported
Abdullah et al,[42]
2001 RSA Jan-99–
Dec-00
Women ANC/
Attendees: 14
139/ Urban
PMTCT integration:
across ANC, LW,
PNC/ ANC and
LW at primary
healthcare level/
LW at hospital level
ANC: Testing women,
Feeding counseling,
Women prophylaxis/ LW:
Women prophylaxis,
Feeding counseling/ PNC:
Testing infants
Opt-in/ Women: ELISA test
later substitute with rapid
test; Infants: antibody test/
Women: AZT; Infants: -
ANC: Percentage of women who received
information on PMTCT; Percentage of
women tested; Percentage of women who
received their test result; Percentage of HIV
positive women who received their test
result; Percentage of women receiving ARV
prophylaxis/ LW: Percentage of women
receiving ARV prophylaxis
Behets et al, [50]
2009 DRC
Jun-03 –Jul-05
Women ANC/
Attendees: 45
262/ Urban
PMTCT Integration:
ANC, LW/ LW at
hospital level
ANC: Testing women,
Women prophylaxis/ LW:
Women prophylaxis,
Infant prophylaxis
Opt-in/ Women:
unspecified; Infants: - /
Women: sd-NVP;
Infants: sd-NVP
ANC: Percentage of women who received
their test result; Percentage of HIV positive
women who received their test result;
Percentage of women receiving ARV
prophylaxis/ LW: Percentage of women
receiving ARV prophylaxis/ PNC:
Percentage of infants receiving ARV
prophylaxis
Bharucha et al,[72]
2005 India Apr-01–
Mar-02
Women LW/
Eligible: 1308/
Urban
PMTCT integration:
LW/ LW at hospital
level
LW: Testing women,
Women prophylaxis
Opt-in/ Women: rapid
test (+ confirmatory test);
Infants: - / Women:
sd-NVP or AZT during
delivery; Infants: -
LW: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women
receiving ARV prophylaxis
Deschamps
et al,[67] 2009 Haiti
Jun-05- Jun-05
Women ANC/
HIV tested:
5270/ Urban
PMTCT integration:
ANC, PNC
ANC: Testing women,
Women ART, Women
prophylaxis/ LW: Women
prophylaxis/ PNC: Feeding
counseling, Testing
infants, infant prophylaxis
Opt-in/ Women: rapid
test; Infants: PCR within
the first 6 months of life/
Women: sd-NVP or AZT
orally during delivery;
Infants : AZT for 1 week
ANC: Percentage of women tested,
Percentage of women receiving ARV
prophylaxis
Doherty et al,[67]
2005 RSA
Jan-02 – Dec-02
Women ANC/
Attendees: 84
406/ Urban and
rural
PMTCT integration:
across ANC, LW,
PNC/ ANC at
primary healthcare
level/ LW at
hospital level
ANC: Testing women,
Feeding counseling,
Women prophylaxis/ LW:
Infant prophylaxis/ PNC:
Testing infants
-/ Women: rapid test;
Infants: antibody test/
Women: sd-NVP; Infants:
sd-NVP
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women who
received their test result, Percentage of
women receiving ARV prophylaxis/ PNC:
Percentage of infants receiving ARV
prophylaxis, Percentage of infants tested,
Percentage of exposed infants who
resulted HIV negative
Ekouevi et al,[43]
2004 Coˆte d’Ivoire
May- 00- Oct-02
Women ANC/
Counseled on
PMTCT: 14 067/
Rural
PMTCT integration:
ANC, LW/ ANC at
primary healthcare
level/ LW at
hospital level
ANC: Testing women,
Feeding counseling,
Women prophylaxis/ LW:
Women prophylaxis,
Infant prophylaxis
Opt-in/ Women: rapid
test (+ confirmatory test);
Infants: -/ Women AZT
from 36weeks plus sd-NVP;
Infants: -
ANC: Percentage of women who received
their test result, Percentage of HIV positive
women who received their test result,
Percentage of women receiving ARV
prophylaxis
Garcia et al,[41]
2005 Colombia
Mar-03- Mar-05
Women ANC/
HIV tested:
200 853/ Urban
and Rural
PMTCT integration:
across ANC, LW,
PNC/ ANC at
primary healthcare
level/ LW at
hospital level
ANC: Testing women/ LW:
Women prophylaxis, Safe
delivery, Infant
prophylaxis/ PNC: Testing
infants
Opt-in/ Women: ELISA and
Western blot; Infants: Viral
load within first 6 months
of life/ Women: AZT-3TC/
AZT-3TC-NVP during
pregnancy, AZT / sd-NVP/
AZT+sd-NVP at delivery;
Infants: AZT+3TC for
6 weeks
ANC: Percentage of women receiving ARV
prophylaxis/ LW: Percentage of women
receiving ARV prophylaxis, Percentage of
women having elective caesarean section/
PNC: Percentage of infants receiving ARVs
prophylaxis, Percentage of infants tested,
Percentage of exposed infants who
resulted HIV negative
Geddes et al,[66]
2008 RSA Mar-04 –
Aug-05
Women ANC/
Attendees: 2624/
Urban
PMTCT integration:
across ANC,
LW, PNC/ ANC
and LW at hospital
level
ANC: Testing women,
Feeding counseling,
Women ART, Women
prophylaxis/ LW: Women
prophylaxis, Safe delivery,
Infant prophylaxis/ PNC:
Testing infants
Opt-in/ Women: rapid test;
Infants: PCR within the
first 6 months of life/
Women: AZT during
pregnancy, sd-NVP/
AZT+sd-NVP at delivery
or HAART for life; Infants:
sd-NVP/ AZT+sd-NVP
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women who
received their test result, Percentage of
women receiving ARV prophylaxis/ LW:
Percentage of women having elective
caesarean section/ PNC: Percentage of
infants receiving ARVs prophylaxis,
Percentage of infants tested, Percentage of
exposed infants who resulted HIV negative
Hillis et al,[73]
2007 Russia
Apr-04 – Oct-04
Women LW/
Eligible for HIV
test: 709/ Urban
PMTCT
integration: LW
LW: Testing women,
Women prophylaxis,
Infant prophylaxis
-/ Women: EIA and
Western blot; Infants: - /
Women: sd-NVP; Infants:
sd-NVP
LW: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women
receiving ARV prophylaxis
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Table 1. Cont.
Author/Year/
Location/Study
period
Participants/
Sample size
(n)/Setting Settings Program Integration
Opt in vs opt out/Type
of HIV test/ARV regimen
(Woman/Infant) Primary outcomes reported
Homsy et al,[52]
2006 Uganda
Dec-04 – Sept-05
Women ANC/
Attendees:
3765/ Rural
PMTCT integration:
across ANC, LW,
PNC/ ANC and
LW at hospital level
ANC: Testing women,
Women ART (referral),
Feeding counseling,
Women prophylaxis/ LW:
Testing women, Feeding
counseling, Women
prophylaxis, Infant
prophylaxis/ PNC:
Testing infants
Opt-out/ Women:
rapid test; Infants: -/
Women: sd-NVP; Infants:
sd-NVP
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women
receiving ARV prophylaxis/ LW: Percentage
of women who received information on
PMTCT, Percentage of women tested,
Percentage of women receiving ARV
prophylaxis/ PNC: Percentage of Infants
receiving ARV prophylaxis
Kanshana et al,[74]
2000 Thailand
Jul-98 - Jun-99
Women ANC/
Attendees: 60
403/ Urban
and Rural
PMTCT integration:
across ANC, LW,
PNC/ LW at
hospital level
ANC: Testing women,
Feeding counseling,
Women prophylaxis/ LW:
Women prophylaxis/ PNC:
Testing infants
Opt-in/ Women: rapid
test (+ confirmatory test);
Infants: antibody test/
Women: AZT from
36 weeks and delivery;
Infants: -
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested/ LW: Percentage of women
receiving ARV prophylaxis
Karcher et al,[53]
2006 Tanzania
Uganda Mar-02 –
Dec-04
Women ANC/
Tanzania
Attendees: 22
664/ Uganda
Attendees: 29
520/ Urban
and rural
PMTCT integration:
across ANC, LW,
PNC/ ANC at
primary healthcare
level/ LW at
hospital level
ANC: Testing women,
Women prophylaxis/ LW:
Women prophylaxis, Infant
prophylaxis/ PNC: Feeding
counseling
-/ Women: rapid test;
Infants: - / Women:
sd-NVP; Infants: sd-NVP
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women
receiving ARV prophylaxis/ LW: Percentage
of women receiving ARV prophylaxis/ PNC:
Percentage of Infants receiving ARVs
prophylaxis
Kasenga et al,[54]
2007 Malawi
Jan-05 – Jun-05
Women ANC/
Attendees:
719/ Rural
PMTCT integration:
across ANC, LW,
PNC/ ANC and
LW at hospital level
ANC: Testing women,
Women prophylaxis/ LW:
Infant prophylaxis/ PNC:
Feeding counseling,
Testing infants
Opt-out/ Women:
unspecified; Infants:
antibody test/ Women:
sd-NVP; Infants: sd-NVP
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women
receiving ARV prophylaxis/ LW: Percentage
of women receiving ARV prophylaxis/ PNC:
Percentage of infants receiving ARV
prophylaxis
Kirere et al,[55]
2008 DRC
Dec-02 – Dec-04
Women ANC/
HIV tested:
5016/ Rural
PMTCT integration:
ANC, LW/ ANC
and LW at
hospital level
ANC: Testing women/ LW:
Women prophylaxis, Infant
prophylaxis
-/ Women: rapid test;
Infants: - / Women:
sd-NVP; Infants: sd-NVP
LW: Percentage of women receiving ARV
prophylaxis/ PNC: Percentage of infants
receiving ARV prophylaxis
Kissin et al,[75]
2008 Russia
Apr-04 – Apr-05
Women LW/
Eligible for HIV
test: 4117/
Urban
PMTCT integration:
across ANC, LW,
PNC/ LW at
hospital level
ANC: Testing women/ LW:
Testing women, Feeding
counseling, Women
prophylaxis, Infant
prophylaxis, Women ART
(referral), Testing infants/
PNC: Testing infants
Opt-out/ Women: rapid
test (+ confirmatory test);
Infants; PCR within the
first six months of life/
Women: sd-NVP; Infants:
sd-NVP
LW: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women
receiving ARV prophylaxis/ PNC:
Percentage of infants receiving ARV
prophylaxis, Percentage of infants tested,
Percentage of exposed infants who
resulted HIV negative
Kuam et al,[56]
2006 Cameroon
Jan-03 – Dec-04
Women ANC/
Attendees: 432/
Urban
PMTCT integration:
across ANC, LW,
PNC/ ANC and
LW at hospital level
ANC: Testing women,
Women prophylaxis/ LW:
Safe delivery, Feeding
counseling, Women
prophylaxis, Infant
prophylaxis/ PNC:
Feeding counseling,
Testing infants
-/Women: rapid test (+
confirmatory test); Infants:
Viral load/ Women: sd-NVP;
Infants: sd-NVP
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women who
received their test result, Percentage of HIV
positive women who received their test
result, Percentage of women receiving ARV
prophylaxis/ LW: Percentage of women
having elective caesarean section/ PNC:
Percentage of infants receiving ARV
prophylaxis, Percentage of infants tested,
Percentage of exposed infants who
resulted HIV negative
Le et al,[76] 2008
Vietnam Jan-00 –
Oct-02
Women ANC;
Women
LW/ Total
attendees: 215
683/ Urban
PMTCT integration:
ANC, LW/ LW at
hospital level
ANC: Testing women,
Women prophylaxis/ LW:
Testing women, Feeding
counseling, Women
prophylaxis, Infant
prophylaxis
Mandatory/ Women:
EIA (+ confirmatory test);
Infants: - / Women:
sd-NVP or AZT at
delivery; Infants:
sd-NVP/AZT +sd-NVP
LW: Percentage of women receiving ARV
prophylaxis/ PNC: Percentage of infants
receiving ARVs prophylaxis
Magoni et al,[57]
2007 Uganda
Jan-00 – Dec-04
Women ANC/
Attendees: 26
556/ Urban
PMTCT integration:
ANC, PNC/ ANC at
hospital level
ANC: Testing women,
Feeding counseling,
Women prophylaxis,
Testing infants/ PNC:
Testing infants
-/Women: rapid test;
Infants: antibody test/
Women: AZT from
36 weeks, AZT or
sd-NVP at delivery;
Infants: -
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women
receiving ARV prophylaxis/ PNC:
Percentage of infants tested, Percentage of
exposed infants who resulted HIV negative
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Table 1. Cont.
Author/Year/
Location/Study
period
Participants/
Sample size
(n)/Setting Settings Program Integration
Opt in vs opt out/Type
of HIV test/ARV regimen
(Woman/Infant) Primary outcomes reported
Malyuta et al,[81]
2006 Ukraine
Jan-02 – Dec-02
Women ANC/
Attendees: 408
354/ Urban
PMTCT integration:
across ANC
(HIV Clinic), LW,
PNC/ ANC at primary
healthcare level/
LW at hospital level
ANC: Testing women,
Women prophylaxis/ LW:
Testing women, Women
prophylaxis, Infant
prophylaxis/ PNC: Testing
infants/ AIDS center:
Feeding counseling,
Testing infants
Opt-in/Women: ELISA in
ANC, rapid test at LW;
Infants: antibody test/
Women: AZT from
36 weeks, AZT or sd-NVP
at delivery; Infants:
sd-NVP
ANC: Percentage of women tested,
Percentage of women receiving ARV
prophylaxis/ LW: Percentage of women
receiving ARV prophylaxis
Manzi et al,[58]
2005 Malawi
Mar-02 – Sep-03
Women ANC/
Attendees:
3136/-
PMTCT integration:
across ANC, LW,
PNC/ ANC and LW
at hospital level
ANC: Testing women,
Safe delivery, Feeding
counseling, Women
prophylaxis/ LW: Safe
delivery, Feeding
counseling, Women
prophylaxis, Infant
prophylaxis/ PNC:
Testing infants
Opt-out/ Women:
rapid test; Infants:
antibody test/ Women:
sd-NVP; Infants: sd-NVP
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women who
received their test result, Percentage of HIV
positive women who received their test
result, Percentage of women receiving ARV
prophylaxis/ LW: Percentage of women
receiving ARV prophylaxis/ PNC:
Percentage of infants receiving ARVs
prophylaxis
Miranda et al,[68]
2005 Brazil
1997 – 2001
Women ANC/
Attendees: 25
224/ Urban
PMTCT integration:
across ANC, LW,
PNC/ ANC at
primary healthcare
level/ LW at
hospital level
ANC: Testing women,
Women prophylaxis/ LW:
Testing women, Feeding
counseling, Women
prophylaxis, Infant
prophylaxis/ PNC:
Testing infants
Opt-out/ Women:
ELISA (+ confirmatory
test); Infants: PCR within
the first six months of
life/ Women: AZT from
14 weeks and delivery;
Infants: AZT for 6 weeks
ANC: Percentage of women receiving ARV
prophylaxis/ LW: Percentage of women
receiving ARV prophylaxis, Percentage of
women having elective caesarean section/
PNC: Percentage of infants receiving ARVs
prophylaxis, Percentage of infants tested,
Percentage of exposed infants who
resulted HIV negative
Moth et al,[59]
2005 Kenya
Feb-03 – Mar-03
Women ANC/
Attendees: 1268/
Urban
PMTCT integration:
ANC, LW/ ANC
and LW at
hospital level
ANC: Testing women/
LW: Women prophylaxis,
Infant prophylaxis
-/ Women: unspecified;
Infants: - / Women:
sd-NVP; Infants: sd-NVP
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested/ LW: Percentage of women
receiving ARV prophylaxis/ PNC:
Percentage of infants receiving ARVs
prophylaxis
Msellati et al,[44]
2001 Coˆte d’Ivoire
Oct-98 - Apr- 99
Women ANC/
Attendees:
4309/ Urban
PMTCT integration:
ANC, LW/ ANC at
primary healthcare
level/ LW at
hospital level
ANC: Testing women,
Feeding counseling,
Women prophylaxis/ LW:
Women prophylaxis
Opt-in/ Women: ELISA test;
Infants: - / Women:
AZT from 36 weeks and
delivery; Infants: -
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women who
received their test result, Percentage of HIV
positive women who received their test
result, Percentage of women receiving ARV
prophylaxis/ LW: Percentage of women
receiving ARV prophylaxis
Nagdeo et al,[77]
2007 India
Feb-03 – Jun-06
Women ANC/
Attendees:
7897/ Rural
PMTCT integration:
ANC, LW/ ANC at
primary healthcare
level/ LW at
hospital level
ANC: Testing women/ LW:
Women prophylaxis,
Infant prophylaxis
-/ Women: unspecified;
Infants: - / Women:
sd-NVP; Infants: sd-NVP
LW: Percentage of women receiving ARV
prophylaxis/ PNC: Percentage of infants
receiving ARV prophylaxis
Onah et al,[45]
2008 Nigeria
Mar-05 - Sept-05
Women ANC/
Attendees:
635/ Urban
PMTCT integration:
ANC, LW/ ANC
and LW at
hospital level
ANC: Testing women,
Feeding counseling,
Women prophylaxis, Safe
delivery/ LW: Women
prophylaxis, Safe delivery,
Infant prophylaxis,
Feeding counseling
Opt-out/ Women: ELISA
and Western blot;
Infants: - / Women:
sd-NVP; Infants: sd-NVP
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women who
received their test result, Percentage of HIV
positive women who received their test
result/ LW: Percentage of women receiving
ARV prophylaxis, Percentage of women
having elective caesarean section/ PNC:
Percentage of infants receiving ARVs
prophylaxis
Pai et al,[78]
2008 India
Jan-06 – Sep-06
Women LW/
Eligible for HIV
test: 1252/ Rural
PMTCT integration:
LW, PNC/ LW at
hospital level
LW: Testing women,
Feeding counseling,
Women prophylaxis,
Safe delivery, Infant
prophylaxis/ PNC:
Testing infants,
Feeding counseling
-/ Women: rapid test
(+confirmatory test);
Infants: PCR within the
first 6 months of life/
Women: AZT-3TC-sd-NVP
during delivery plus
AZT-3TC 1 week after
delivery; Infants:
sd-NVP + AZT for 1 week
LW: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women
receiving ARV prophylaxis/ PNC:
Percentage of infants receiving ARVs
prophylaxis, Percentage of infants tested,
Percentage of exposed infants who
resulted HIV negative
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Table 1. Cont.
Author/Year/
Location/Study
period
Participants/
Sample size
(n)/Setting Settings Program Integration
Opt in vs opt out/Type
of HIV test/ARV regimen
(Woman/Infant) Primary outcomes reported
Parameshwari
et al,[79] 2009
India Oct-02 –
Dec-07
Women ANC/
Attendees:
7866/ Rural
PMTCT integration:
across ANC, LW,
PNC/ ANC and
LW at hospital level
ANC: Testing women,
Feeding counseling,
Women prophylaxis/ LW:
Women prophylaxis,
Infant prophylaxis,
PNC, Testing infants
-/ Women: rapid
test (+ confirmatory
test); Infants: PCR within
the first 6 months of life/
Women: sd-NVP; Infants:
sd-NVP
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women
receiving ARV prophylaxis/ PNC:
Percentage of infants receiving ARV
prophylaxis, Percentage of infants tested,
Percentage of exposed infants who
resulted HIV negative
Perez et al,[46,94]
2004 Zimbabwe
Aug-01- Feb-03
Women ANC/
Attendees:
2470/ Rural
PMTCT integration:
across ANC, LW,
PNC/ ANC and
LW at hospital level
ANC: Testing women,
Feeding counseling/ LW:
Women prophylaxis,
Infant prophylaxis/ PNC:
Feeding counseling
Opt-in/ Women: rapid test;
Infants: - /Women: sd-NVP;
Infants: sd-NVP
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women who
received their test result, Percentage of HIV
positive women who received their test
result, Percentage of women receiving ARV
prophylaxis/ LW: Percentage of women
receiving ARV prophylaxis/ PNC:
Percentage of infants receiving ARVs
prophylaxis
Rose et al,[60]
2005 RSA
Jan-03 – Dec-05
Women LW/
Eligible for
HIV test:
7500/ Urban
PMTCT integration:
LW (postpartum)/ LW
at hospital level
LW: Testing women,
Infant prophylaxis,
Feeding counseling
-/ Women: rapid
test (+ confirmatory
test); Infants: - /
Women: - ; Infants:
sd-NVP
LW: Percentage of women who received
information on PMTCT, Percentage of
women tested/ PNC: Percentage of infants
receiving ARVs prophylaxis
Rutta et al,[47]
2008 Tanzania
Oct-02 – Sep-04
Women ANC/
Attendees: 10
666/ Refugees
camp
PMTCT integration:
across ANC, LW,
PNC/ ANC at
primary healthcare
level/ LW at
hospital level
ANC: Testing women,
Feeding counseling,
Safe delivery, Women
prophylaxis/ LW: Safe
delivery, Women
prophylaxis, Infant
prophylaxis/ PNC:
Testing infants
Opt- out/ Women:
rapid test (+ confirmatory
test); Infants: antibody
test/ Women: sd-NVP;
Infants: sd-NVP
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women who
received their test result, Percentage of HIV
positive women who received their test
result, Percentage of women receiving ARV
prophylaxis/ LW: Percentage of women
receiving ARV prophylaxis/ PNC:
Percentage of infants receiving ARV
prophylaxis, Percentage of infants tested,
Percentage of exposed infants who
resulted HIV negative
Saman et al,[80]
2002 Cambodia
July-00 – Jun-01
Women ANC/
Attendees:
2079/ Urban
PMTCT integration:
across ANC, LW,
PNC/ ANC and
LW at hospital level
ANC: Testing women,
Feeding counseling/ LW:
Testing women, Women
prophylaxis, Infant
prophylaxis, Feeding
counseling/ PNC:
Testing infants
-/ Women: rapid
test (+ confirmatory
test); Infants: PCR within
the first 6 months of life/
Women: sd-NVP; Infants:
sd-NVP
ANC: Percentage of women who received
their test result/ LW: Percentage of women
who received information on PMTCT,
Percentage of women tested, Percentage
of women receiving ARV prophylaxis/ PNC:
Percentage of infants receiving ARVs
prophylaxis
Saraceni et al,[69]
2000 Brazil
Jun-97 – Jun-05
Women ANC/
Attendees: 202
950-
PMTCT integration:
across ANC, LW,
PNC/ LW at
hospital level
ANC: Testing women,
Feeding counseling,
Women ART (referral),
Women prophylaxis/ LW:
Women prophylaxis, Safe
delivery, Infant
prophylaxis/ PNC: Feeding
counseling, Testing infants
-/ Women: ELISA
substituted with rapid
test; Infants: antibody
test/ Women: AZT during
pregnancy and delivery;
Infants: AZT
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women
receiving ARV prophylaxis/ LW: Percentage
of women receiving ARV prophylaxis,
Percentage of women having elective
caesarean section/ PNC: Percentage of
infants tested, Percentage of exposed
infants who resulted HIV negative
Schumacher
et al,[70] 2009
Guyana Jan-06 –
Mar-06
Women LW/ HIV
status unknown:
360
PMTCT integration:
LW/ LW at hospital
level
LW: Testing women,
Women prophylaxis,
Infant prophylaxis
-/ Women: unspecified;
Infants: - / Women:
sd-NVP, Infants: sd-NVP
LW: Percentage of women who received
information on PMTCT, Percentage of
women tested/ PNC: Percentage of infants
receiving ARV prophylaxis
Shetty et al,[62]
2005 Zimbabwe
July-99 - June-01
Women ANC/
Attendees:
6051/ Urban
PMTCT integration:
ANC/ ANC at
primary healthcare
level
ANC: Testing women,
Women prophylaxis
Opt-in/ Women: rapid
test (+ confirmatory test);
Infants: - / Women:
AZT from 36 weeks;
Infants: -
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women who
received their test result, Percentage of HIV
positive women who received their test
result, Percentage of women receiving ARV
prophylaxis
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study, HIV testing in antenatal care and at labor ward was
mandatory and women had to pay for it. Given that women had to
wait for the results of the tests for at least one week, most of the
women who were tested at labor ward and their infants did not
receive ARV treatment. The authors stated that 28.3% of the HIV
positive women and 4.1% of their infants received ARV
prophylaxis. The study did not report separate results for women
tested in antenatal care and those tested at labor ward [76].
The proportion of women counseled on infant feeding was not
explicitly stated in any of the included studies but most of them
reported that women participating in PMTCT programs received
infant feeding recommendation as a part of the counseling.
Table 1. Cont.
Author/Year/
Location/Study
period
Participants/
Sample size
(n)/Setting Settings Program Integration
Opt in vs opt out/Type
of HIV test/ARV regimen
(Woman/Infant) Primary outcomes reported
Shetty et al,[61]
2008 Zimbabwe
Oct-02 - Dec-04
Women ANC/
Attendees: 19
279/ Urban
PMTCT integration:
across ANC, LW,
PNC (Immunization
clinic)/ ANC at
primary healthcare
level/ LW at
hospital level
ANC: Testing women,
Feeding counseling,
Women prophylaxis/ LW:
Women prophylaxis,
Infant prophylaxis/ PNC:
Testing infants
Opt-in/ Women: rapid test;
Infants: antibody test/
Women: sd-NVP;
Infants: sd-NVP
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women who
received their test result, Percentage of HIV
positive women who received their test
result, Percentage of women receiving ARV
prophylaxis/ LW: Percentage of women
receiving ARV prophylaxis/ PNC:
Percentage of infants receiving ARVs
prophylaxis
Stringer et al,[48]
2003 Zambia
Nov-01- Oct-02
Women ANC/
Counseled on
PMTCT: 17 263/
Urban
PMTCT integration:
across ANC, LW,
PNC/ LW at
hospital level
ANC: Testing women,
Women prophylaxis,
Feeding counseling/ LW:
Women prophylaxis,
Infant prophylaxis/ PNC:
Testing infants
Opt-in/ Women: rapid test;
Infants: antibody test/
Women: sd-NVP;
Infants: sd-NVP
ANC: Percentage of women who received
their test result, Percentage of women
receiving ARV prophylaxis
Temmerman et
al,[49] 2003 Kenya
Apr- 01 - Apr- 02
Women ANC/
Attendees:
3660/ Urban
PMTCT integration:
ANC, LW/ ANC
and LW at hospital
level
ANC: Testing women,
Feeding counseling,
Women prophylaxis,
Infant prophylaxis/ LW:
Women prophylaxis,
Infant prophylaxis
Opt-in/ Women: rapid test;
Infants: - / Women: sd-NVP;
Infants: sd-NVP, provided at
ANC to administer during
home delivery
ANC: Percentage of women who received
information on PMTCT, Percentage of
women tested, Percentage of women who
received their test result, Percentage of HIV
positive women who received their test
result, Percentage of women receiving ARV
prophylaxis/ LW: Percentage of women
receiving ARV prophylaxis
Torpey et al,[63]
2010 Zambia
Jul-05 – Sep-08
Women ANC/
Counseled on
PMTCT:
34 780/ Urban
and Rural
PMTCT Integration:
across ANC, LW,
PNC (Immunization
clinic)/ANC at
primary healthcare
level/ LW at
hospital level
ANC: Testing women,
Women prophylaxis
Opt-out/ Women: rapid test
(+ confirmatory test); Infants:
PCR within the first 6 months
of life/ Women: sd-NVP;
Infants: sd-NVP
ANC: Percentage of women who received
their test result, Percentage of HIV positive
women who received their test result,
Percentage of women receiving ARV
prophylaxis
Viani et al,[71]
2010 Mexico
Mar- 03 - Dec-05
Women ANC/
17 at ANC and
45 at LW/
Urban
PMTCT integration:
across ANC, LW,
PNC/ ANC and
LW at hospital level
ANC: Testing women,
Feeding counseling,
Women prophylaxis/ LW:
Testing women, Women
prophylaxis, Safe delivery,
Infant prophylaxis,
Feeding counseling/ PNC:
Testing infants
-/ Women: rapid test (+
confirmatory test); Infants:
PCR within the first six
months of life/ Women:
AZT-3TC-NFV during
pregnancy or AZT during
delivery; Infants: AZT for
6 weeks
ANC: Percentage of women receiving ARV
prophylaxis, Percentage of women having
elective caesarean section/ PNC:
Percentage of infants receiving ARV
prophylaxis, Percentage of infants tested,
Percentage of exposed infants who
resulted HIV negative
Wanyu et al,[64]
2007 Cameroo
Jul-02 – Jun-05
Women ANC/
Counseled on
PMTCT: 2331/
Rural
PMTCT integration:
across ANC, LW,
PNC/ ANC at
primary healthcare
level/ LW at hospital
level
ANC: Testing women,
Feeding counseling/ LW:
Women prophylaxis,
Infant prophylaxis/ PNC:
Testing infants
Opt-in/ Women: rapid test;
Infants: antibody test/
Women: sd-NVP; Infants:
sd-NVP
ANC: Percentage of women who received
their test result, Percentage of HIV positive
women who received their test result/ LW:
Percentage of women receiving ARV
prophylaxis/ PNC: Percentage of infants
receiving ARV prophylaxis, Percentage of
infants tested, Percentage of exposed
infants who resulted HIV negative
Welty et al,[65]
2005 Cameroon
Feb-00 – Dec-04
Women ANC;
Counseled on
PMTCT: 68 635/
Urban and rural
PMTCT integration:
across ANC, LW,
PNC/ ANC at
primary healthcare
level/ LW at
hospital level
ANC: Testing women,
Feeding counseling,
Women prophylaxis/ LW:
Women prophylaxis,
Infant prophylaxis/
PNC:Testing infants
-/ Women: rapid test;
Infants: PCR within
the first 6 months of
life/ Women: sd-NVP;
Infants: sd-NVP
ANC: Percentage of women who received
their test result, Percentage of HIV positive
women who received their test result/ PNC:
Percentage of exposed infants who
resulted HIV negative
Abbreviations: ANC, antenatal care; ART, antiretroviral therapy; ARV, antiretroviral; AZT, zidovudine; DRC, Democratic Republic of Congo; EIA, enzyme immunoassay;
ELISA, enzyme-linked immunosorbent assay; HAART, highly active antiretroviral therapy; LW, labor ward; NVF, nelfinavir; PMTCT, prevention of mother to child
transmission; PCR, polymerase chain reaction; PNC, postnatal care; RSA, Republic of South Africa; sd-NVP, single dose nevirapine;3TC, lamivudine.
doi:10.1371/journal.pone.0056550.t001
The Uptake of Integrated PMTCT Programs
PLOS ONE | www.plosone.org 9 March 2013 | Volume 8 | Issue 3 | e56550
PMTCT cascades. The first cascade captures all the steps of
the PMTCT program; from the pre-test counseling in antenatal
care to the infant prophylaxis (Figure 2). It is based on the data
from four studies reporting the uptake of each of the PMTCT
interventions [46,47,58,61]. All studies were conducted in low-
income sub-Saharan African countries and employed HIV rapid
test and single dose nevirapine as ARV prophylaxis for both
women and infants. Although most of the women attending
antenatal care received pre-test counseling, only 70% of them
accepted HIV testing and only 65% of those women received their
test result.
About 14% of women attending the antenatal care received an
HIV positive result. We estimated that an additional 4% of
antenatal care attendees were HIV positive and unaware of their
HIV status because they either were not counseled, were not
tested, or did not receive test results. This translates to 22% of total
HIV positive women attending the antenatal care who were not
notified about their HIV status.
Only half of all HIV positive women attending the antenatal
care were provided with ARV prophylaxis in antenatal care.
Seventeen per cent of all HIV positive women attending the
antenatal care were observed or self-reported to have taken the
provided ARV prophylaxis at delivery. Similarly, only 17% of the
infants born to all HIV positive women that attended antenatal
care received ARV prophylaxis.
The second cascade presents the drop-outs of integrated
PMTCT with labor ward (Figure 3) based on the results of three
studies providing outcomes for PMTCT interventions provided in
labor ward [52,75,78]. Ninety eight per cent of eligible women
were counseled in labor ward and 89% of them were tested for
HIV. Eighty nine per cent of all HIV positive women attending
labor ward were diagnosed as infected. We estimated that an
additional 11% of all HIV positive were women attending labor
ward were not identified as HIV-positive. Seventy eight per cent of
all HIV positive women attending labor ward received ARV
Table 2. Uptake of integrated PMTCT programs in which women were enrolled in antenatal care.
World Bank Income Group Low Income
Lower Middle
Income
Upper Middle
Income ALL P
Median (range)n
studies
Median (range) n
studies
Median (range) n
studies
Median (range) n
studies
Percentage of ANC attendees who received
information on PMTCT
92% (30–98%) 12 100% (87–100%) 5 100% (100–100%) 4 96% (30–100%) 21 0.001a
Percentage of ANC attendees HIV tested 69% (26–95%) 12 89% (80–100%) 6 81% (56–100%) 4 81% (26–100%) 22 0.048b
Percentage of HIV tested ANC attendees
who received HIV test result
89% (74–100%) 10 81% (67–100%) 6 99% (85–100%) 3 87% (67–100%) 19 0.680
Percentage of HIV positive ANC attendees
who received HIV test result
93% (75–100%) 8 92% (60–100%) 6 96% (92–100%) 2 94% (60–100%) 16 0.957
Percentage of HIV positive ANC attendees
given ARV prophylaxis at ANC
53% (33–99%) 14 40% (22–89%) 5 60% (44–97%) 6 55% (22–99%) 25 0.784
Percentage of HIV positive ANC attendees
given ARV prophylaxis at LW (on
women who delivered at LW)
70% (19–100%) 11 70% (14–91%) 6 76% (43–95%) 5 74% (14–100%) 22 0.767
Percentage of HIV positive ANC attendees
known to have taken ARV prophylaxis at
delivery (self-reported and observed by nurses)
38% (19–75%) 12 60% (14–69%) 5 72% (43–85%) 5 52% (14–85%) 22 0.099
Abbreviations: ANC, antenatal care; ARV, antiretroviral; LW, labor ward; PMTCT, prevention of mother to child transmission.
aRankSumTrend test P=0.001.
bRankSumTrend test P= 0.136.
doi:10.1371/journal.pone.0056550.t002
Table 3. Uptake of integrated PMTCT programs in which women were enrolled at a labor ward.
World Bank income group Low income
Lower middle
income
Upper middle
income All P
Median (range) n
studies
Median (range) n
studies
Median (range) n
studies
Median (range) n
studies
Percentage of women delivering at LW
who received information on PMTCT
69% (53–84%) 2 68% (59–100%) 3 100% (77–100%) 3 80% (53–100%) 8 0.306
Percentage of women delivering at LW
who were HIV tested
59% (45–72%) 2 68% (44–98%) 3 89% (51–95%) 3 70% (44–98%) 8 0.505
Percentage of HIV positive women delivering
at LW given ARV prophylaxis
100% (N/A) 1 100% (100–100%) 2 77% (48–84%) 3 92% (48–100%) 6 0.351
Percentage of infants of HIV positive women
delivering at LW given ARV prophylaxis
94% (89–100%) 2 88% (75–100%) 2 96% (85–98%) 3 96% (75–100%) 7 0.558
Abbreviations: ARV, antiretroviral; LW, labor ward; PMTCT, prevention of mother to child transmission of HIV.
doi:10.1371/journal.pone.0056550.t003
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prophylaxis as well as 78% of the infants. The prevalence of HIV
among the HIV tested women in the included studies was 2,8%.
Secondary outcomes. Percentage of HIV positive infants
born to women living with HIV. Thirteen studies reported the
uptake of infant HIV testing. A median of 11% (range 3–18%) of
infants were found to be HIV positive
[41,47,51,56,57,64,66,68,69,71,75,78,79].
Cost analysis. Three studies provided data on the costs of
interventions [48,58,60].
A 12-month program in Zambia was estimated to cost US$ 221
170. This included start-up costs and recurring costs such as staff
salaries and HIV test kits, but excluded expatriate salaries and
travel expenses. Subtracting the start-up costs from the overall
expenditure, the costs were US$ 9.34 per woman counseled, US$
12.96 per woman tested and US$ 55.12 for identifying one
seropositive woman. This program was funded by the Elizabeth
Glaser Pediatric AIDS Foundation [48].
In a South African program the estimated costs per woman
enrolled in a postpartum VCT program were US$ 23; these costs
included testing women and administering nevirapine to infants
whose women were positive [60].
The costs of preventing one HIV child infection was estimated
in two studies to range from US$ 848 in a Zambian study (where
the initial costs of salaries, training, medical materials, equipment
were excluded) [48], to US$ 4444 in a Malawian study (where all
the initial costs were included) [58].
Impact of integration on human resources. A number of
studies reported that the integration of programs led to increased
staff workload [51,52,59,74] and that additional personnel was
employed [44,46,47,51,52,57,58,60,78]. New personnel hired
were mostly counselors [44,46,58,60,78]. In some programs
traditional birth attendants, lay counselors or peer-counselors
were additionally employed [46,51,60–65].
One study reported that nurses received compensation because
of extra work [63] and in a Zambian study the nurses were allowed
to schedule counseling on their off-days for extra pay [48]. Heavy
workload on personnel without extra pay was identified as
potentially having a negative impact on the success of the program
in the long-term [49].
Table 4. Uptake of PMTCT interventions by infants born to HIV positive women.
World Bank income group Low income
Lower middle
income
Upper middle
income All P
Median (range) n
studies
Median (range) n
studies
Median (range) n
studies
Median (range) n
studies
Percentage of infants of HIV positive
women given ARV prophylaxis
90% (24–100%) 12 100% (75–100%) 7 98% (85–100%) 7 97% (24–100%) 26 0.327
Percentage of infants of HIV positive
women HIV tested at least once
67% (54–79%) 2 74% (44–100%) 4 82% (50–100%) 7 79% (44–100%) 13 0.548
Abbreviations: ARV, antiretroviral.
doi:10.1371/journal.pone.0056550.t004
Figure 2. Cascade of integrated perinatal PMTCT program in antenatal care. Blue bars indicate proportion of women participating in
PMTCT program while red bars show the estimated proportion of undiagnosed HIV positive women and diagnosed HIV positive women lost to
follow-up at each step of the PMTCT program.
doi:10.1371/journal.pone.0056550.g002
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Inequalities in access. Three studies identified lack of
means as a key barrier to participation in PMTCT program
[54,59,76]. In a study from Vietnam, there was a low uptake of
HIV testing due to service charges. In the same study women were
counseled to use infant formula which was provided for free only
during the hospital stay but was unaffordable after discharge for
most women [76]. In two studies, women opted for a home
delivery since they were unable to pay for the maternity services
[54,59].
In some studies women were lost-to follow-up due to lack of
transportation [54,58,67]. In a Ukrainian study authors identified
intravenous drug users as a hard to reach group not attending
antenatal care but reporting to hospital in advanced labor [81].
Confidentiality. Some studies reported that the confidenti-
ality of counseling was not always achieved due to partially opened
doors, interruptions during counseling and lack of space for
counseling [50,59,60]. Several studies presented activities under-
taken to ensure confidentiality of counseling, e.g. additional space
was either built in or designated for counseling [46,47,58,62,63],
and patient confidentiality was emphasized during staff training
[47,62,64,65,78].
Barriers to implementation, access and
sustainability. Several studies identified lack of human, mate-
rial, and financial resources (with stock-outs of HIV test kits, ARV
prophylaxis and ART) as a key barrier to implementation of
integrated care in low- and middle-income countries [50,61–
64,67,74,76].
Social norms and stigma have been described in many studies as
a cause of lower uptake of PMTCT interventions, HIV testing
refusal [48,59,61,62,67], and for preference of breastfeeding even
when formula was provided for free [44,74]. In one study families
left their communities after women were identified as HIV positive
[64]. In a Nigerian program, HIV positive women who were
provided elective caesarean section preferred a vaginal delivery
because of cultural aversion to caesarean section [45]. In a study in
rural Cameroon, the health worker counseled women to
breastfeed their infants instead of using the available formula milk
because replacement feeding was considered culturally unaccept-
able [65].
Complexity of monitoring tools deterred health workers from
completing them or following up women [47,55,74,78]. One study
reported that health workers were reluctant to give ARV
prophylaxis to women in antenatal care as they believed women
would not take the medication provided [50].
Late admission to the labor ward sometimes prevented staff
from testing women for HIV, receiving the result before delivery
and providing them with ARV prophylaxis [70,75,84].
Two studies reported that some HIV positive women
abandoned their children at hospitals [73,76]. These infants did
not receive ARV prophylaxis or HIV testing, as there were no
follow-up services available [76].
The most commonly reported barrier to sustainability was the
lack of financial support. Funding provided by the government or/
and external donors has been reported as crucial for the success
and sustainability of programs [61,65,74,78]. Authors reporting on
the PMTCT program from rural Malawi argued that it should be
decentralized in the future to improve access. However, they also
felt that in that case the provision of free formula would no longer
be affordable [58].
Impact of integration on the use of healthcare services
integrated with PMTCT interventions was reported in only one
study where it did not influence the coverage or flow of women
attending antenatal care given as counseling was provided by
counselors in separate rooms [46].
The remaining secondary outcomes are presented in Text S8.
We presented community involvement strategies employed in the
included studies. We also reported data on provision of ART and
co-trimoxazole to HIV positive mothers and HIV positive infants
after delivery.
Discussion
This is the first systematic review on the uptake of integrated
PMTCT programs in low- and middle-income countries. The
existing evidence provides data on PMTCT programs implement-
ed between 1997 and 2006. The overall uptake of PMTCT
programs was low. The MTCT rate of HIV in included studies
was 11% (range 3–18%). It highlighted many challenges of
following through all the steps of the perinatal PMTCT cascade.
Figure 3. Cascade of integrated PMTCT program at labor ward. Blue bars indicate the proportion of women participating in PMTCT program
at labor ward. Red bars show the estimated proportion of eligible HIV positive women at labor ward, not tested (column 1), not receiving ARV
prophylaxis (column 2) and proportion of infants born to HIV positive women not receiving ARV prophylaxis (column 3).
doi:10.1371/journal.pone.0056550.g003
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Although the uptake of counseling and testing in antenatal care
was high, presumably many HIV positive women did not receive
ARV prophylaxis in antenatal care and did not deliver at a labor
ward. The PMTCT cascade based on the four studies from low-
income sub-Saharan African countries with data on the entire
perinatal PMTCT program showed a marked loss to follow-up
between steps of the program. Only half of HIV positive women
received ARV prophylaxis in antenatal care and 17% were known
to have taken ARV prophylaxis at delivery (either self-reported or
observed at labor ward). We estimated that 22% of all HIV
positive women attending antenatal care and 11% of all HIV
positive women attending labor ward were not tested or notified
about their HIV status. Although the uptake of PMTCT
interventions delivered at labor ward was high, it did not reach
the 80% target set by UNGASS for HIV testing [16].
In a study performed in four African countries cord blood
specimen analysis was used to assess uptake of ARV prophylaxis
instead of process indicators. The unadjusted maternal nevirapine
coverage was 58% (95% CI, 56–59%) [85]. These findings are
strikingly consistent with the findings of this review where 55%
(range 22–99%) of HIV positive women received ARV prophy-
laxis in antenatal care and 52% (range 14–85%) of HIV positive
women were known to have taken ARV prophylaxis. However,
more recent studies generally report lower ingestion of ARV
prophylaxis among HIV positive women within antenatal care
which could be due to the more complicated regimens of ARV
prophylaxis used lately.
The uptake of ARV prophylaxis at labor ward in women
entering PMTCT program at labor ward was 92% compared to
74% of those entering in antenatal care. We assume that this
difference is due to late admission of women to the labor ward.
Identified HIV positive women arriving at the labor wards were
sometimes not provided with ARV prophylaxis because of
imminent delivery and lack of time. Further, in the studies
reviewed women of unknown HIV status arriving to the labor
ward in advanced labor were not tested and diagnosed.
Consequently, they were not considered eligible for ARV
prophylaxis and are not included in the denominator (HIV
positive women delivering at labor ward) misleadingly resulting in
higher proportion of women receiving ARV prophylaxis. Fur-
thermore, the higher proportion of participants receiving ARV
prophylaxis at labor ward compared to the antenatal care could
also be explained by the complexity of the provided ARV
prophylaxis. At labor ward, the ARV prophylaxis consisted mostly
of single dose nevirapine while in antenatal care women also
received more complex regimens. We also observed an excellent
correlation of women and infants receiving ARVs at institutional
delivery.
This review also showed that not all interventions which should
intuitively lead to better outcomes necessarily do so. The opt-out
approach increased the proportion of women tested. However, it is
unclear if it improves uptake of other PMTCT interventions such
as counseling or ARV prophylaxis. Increased awareness of HIV
positive serostatus might not lead to more women participating in
PMTCT program due to other barriers such as health system
failures or fear of stigma. Several studies confirmed higher uptake
of HIV testing when opt-out approach was implemented [86–89].
Studies from Botswana and Ethiopia reported that opt-out testing
lead to better uptake of only testing [86,88]. A Zimbabwean study
reported also an increase in uptake of ARV prophylaxis [89].
Similarly, the implementation of rapid test increased the
proportion of women receiving their test result but the difference
was not significant when only HIV positive women were
considered. Several studies on the effect of rapid test on the
PMTCT intervention uptake reported contrasting findings. Rapid
test contributed to an increase in the proportion of women who
received post-test counseling in two studies [89,90]. In a Kenyan
study significantly fewer HIV positive women were tested with
rapid test and accepted referral for other PMTCT interventions
compared to those receiving conventional tests [91].
Next, the use of virological test for infants, which means a
shorter length of follow up, did not result in a higher proportion of
infants tested.
In many countries significant proportion of women delivers at
home. One strategy for reaching these women and their infants is
the involvement of traditional birth attendants (TBAs). This
approach seems to be effective according to two studies from
Cameroon [64,65]. A further Zimbabwean study examining the
views of TBAs regarding PMTCT programs, reported that TBAs
were willing to participate in most of the PMTCT interventions
[92]. Furthermore, TBAs could potentially act as a link to long-
term HIV care and treatment services for HIV positive women
and children in need of lifelong HAART. This systematic review
has a number of strengths. We undertook a comprehensive and
extensive search of multiple electronic databases of published and
grey literature to identify relevant peer–reviewed studies since the
introduction of the PMTCT. We nether used any methodological
filters, nor specific search terms for integrated care. We followed
methodology principles established by the Cochrane Collabora-
tion and did not apply language restrictions to the search strategy.
A detailed and comprehensive data extraction of the selected
studies has provided us with a broad range of information and
deep insight into the issues surrounding the implementation of
integrated PMTCT programs.
Despite our thorough search strategy, we only found studies
presenting programs implemented before 2007. It could be argued
that the data from our review does not reflect the current,
potentially better PMTCT programs which have, in the last few
years, received substantial financial investments and could have
improved. However, the aforementioned study on uptake in four
African countries during 2007 and 2008 showed very similar
uptake of PMTCT interventions to the one in our review. In
addition, a study presenting national data on PMTCT services in
Ethiopia from 2006 to 2010, showed that uptake was low.
Although there was significant improvement in HIV counseling
and testing uptake during this period, only 53% of known HIV-
positive mothers and 38% of known HIV-exposed infants
attending PMTCT programs have received ARV prophylaxis in
2009.[88] Furthermore, recent WHO PMTCT guidelines recom-
mend more effective and more complicated regimens. Given the
low uptake of simpler PMTCT regimens in the included studies, it
is very important to assess the uptake of more recent PMTCT
programs following new guidelines. It is of concern that we could
not find studies with this information. The potential reason for lack
of this information could be that the studies that we found were
mostly published with the intention to present the feasibility of the
first PMTCT programs. In addition, studies on uptake of PMTCT
interventions are mostly based on routine program data and as
such could potentially be considered as non-publishable in peer-
reviewed journals, especially now that the feasibility of PMTCT
programs has been established. However, the low uptake of these
programs warrants more recent data which would show the
current status of PMTCT services.
The included studies were highly heterogeneous in terms of time
of implementation, content and context of implementation (i.e.
HIV prevalence, type of HIV epidemic, dominant mode of HIV
transmission or countries’ income, training provided to the staff).
However, we have used appropriate statistical methods that
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allowed pooling of the studies. As sample size was limited in each
study, we summarized results based on reported frequencies. This
yielded higher sample size and higher external validity on cost of
biases introduced by the heterogeneity of the studies and their
different sample sizes.
We also found the policy context to be quite variable across the
included studies. The timing of ARV prophylaxis administration
in antenatal care was different and might have also had an impact
on the uptake.
Included studies had several limitations which should be
considered when interpreting these findings. The characteristics
of participants were poorly reported in most of the studies.
Additionally, there was a paucity of information about the setting
of integrated PMTCT care, the nature of intervention and the
content of the training provided to the staff. Although this
systematic review was focused on the integration of service
delivery, we noticed the general lack of data on integration of
other aspects of the health system (e.g. health information systems,
leadership, financing etc.). The studies were mostly based on single
health facilities and given high levels of short-term migration of
women at the time of delivery, might have failed to capture the
potential uptake of ARV prophylaxis at other facilities. Although
we aimed to capture the proportion of women receiving the full
ARV prophylaxis regimen in the antenatal care, in two included
studies we only found data on the proportion of women who
started it. Most of the studies reported who funded the PMTCT
programs, but there was no information on the proportion of
financing from domestic versus international sources, per person
or total annual financing for PMTCT as a proportion of the HIV
or health budget. Many studies did not provide clear, quantitative
data on the proportion of women counseled on infant feeding,
costs, impact on maternal and child healthcare services attendance
and stigma. The information on follow-up of HIV positive women
and infants after the delivery was scarce. We also wanted to
present other aspects of quality of care in the integrated programs
but only found information on confidentiality of counseling.
However, these studies were primarily focused on perinatal
programs, presented programs implemented before the new
WHO guidelines on follow-up. Our ability to detect statistically
significant difference in subgroup analyses was limited by the low
number of studies reporting on coverage of individual interven-
tions.
The findings of our review provide most timely information on
weaknesses in and the uptake of PMTCT cascade at the time
when PMTCT is receiving a reinvigorated commitment and
scaling-up is the highest priority of all main players in global health
from governments to global agencies and financing institutions.
The findings are important and inform the global estimates of the
impact of PMTCT interventions as we provide the most up to date
status of how initial coverage levels translate to effective
prophylaxis for prevention of MTCT of HIV. Models used to
estimate coverage and impact of PMTCT interventions need to
factor adequately for the ’substantial’ attrition rates to produce a
more realistic estimate of coverage impact.
If the ambition of HIV-free and AIDS-free generation is to be
achieved by 2015 [93], implementation strategies for PMTCT
programs need to receive much greater attention for each step of
the cascade.
Future research should in particular focus on the strategies to
improve access to maternal and child healthcare services (perhaps
through more systematic use of mobile phones) and to provide
PMTCT interventions to HIV positive women delivering at home.
Given that the main challenge is reaching the women who are not
attending antenatal care or delivering at a labor ward, it is
necessary to evaluate outreach options and the use of healthcare
services other than maternal and child healthcare programs as
entry points to the PMTCT programs.
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